Viewing StudyNCT03971422



Ignite Creation Date: 2024-05-06 @ 1:15 PM
Last Modification Date: 2024-10-26 @ 1:11 PM
Study NCT ID: NCT03971422
Status: COMPLETED
Last Update Posted: 2023-09-05
First Post: 2019-05-29

Brief Title: A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Generalized Myasthenia Gravis
Keywords:
Name View
gMG View
UCB7665 View
generalized myasthenia gravis View
rozanolixizumab View